Dialysis Corporation of America (DCAI) Reports In-Line Q2 EPS of $0.07
Dialysis Corporation of America (Nasdaq: DCAI) reports Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter was $24.7 million, versus the consensus of $24.78 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
